The effect of ondansetron on cognitive performance in the marmoset (Q52238849)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 1, 1991

edit

Language	Label	Description	Also known as
English	The effect of ondansetron on cognitive performance in the marmoset	scientific article published on January 1, 1991

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

title

The effect of ondansetron on cognitive performance in the marmoset (English)

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

main subject

pharmacology

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

biochemistry

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

author name string

A. M. Domeney

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

B. Costall

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

P. A. Gerrard

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

D. N. Jones

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

R. J. Naylor

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

M. B. Tyers

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1826787

retrieved

3 December 2022

language of work or name

English

0 references

publication date

1 January 1991

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

full work available at URL

https://api.elsevier.com/content/article/PII:0091305791906063?httpAccept=text/xml

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

https://api.elsevier.com/content/article/PII:0091305791906063?httpAccept=text/plain

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

published in

Pharmacology, Biochemistry and Behavior

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

volume

38

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

page(s)

169-175

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

cites work

[3H]zacopride: ligand for the identification of 5-HT3 recognition sites

series ordinal

3

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Identification of 5-HT3 recognition sites in human brain tissue using [3H]zacopride

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Physostigmine and arecoline: effects of intravenous infusions in Alzheimer presenile dementia

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Zacopride: anxiolytic profile in rodent and primate models of anxiety

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Somatostatin content and release measured in cerebral biopsies from demented patients.

series ordinal

15

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Effect of the 5-HT3 receptor antagonist, GR38032F, on responses to injection of a neurokinin agonist into the ventral tegmental area of the rat brain

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Alzheimer's disease

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

series ordinal

20

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Cognition activators

series ordinal

22

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Intravenous nicotine in Alzheimer's disease: a pilot study.

series ordinal

23

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Presynaptic serotonergic dysfunction in patients with Alzheimer's disease

series ordinal

24

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Species variations in 5-HT3 recognition sites labeled by 3H-quipazine in the central nervous system

series ordinal

25

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Reduced binding of [3H]ketanserin to cortical 5-HT2 receptors in senile dementia of the Alzheimer type

series ordinal

26

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

An analysis of visual object reversal learning in the marmoset after amphetamine and haloperidol.

series ordinal

27

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Effects of ibotenic acid lesions of the basal forebrain on serial reversal learning in marmosets

series ordinal

28

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Visuospatial learning impairment following lesion of the cholinergic projection to the hippocampus

series ordinal

29

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease

series ordinal

30

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Impairment in T-maze reinforced alternation performance following nucleus basalis magnocellularis lesions in rats

series ordinal

31

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.

series ordinal

32

1 reference

stated in

Crossref

DOI

10.1016/0091-3057(91)90606-3

reference URL

https://api.crossref.org/works/10.1016/0091-3057(91)90606-3

retrieved

3 December 2022

Identifiers

DOI

10.1016/0091-3057(91)90606-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

PubMed publication ID

1826787

1 reference

stated in

Europe PubMed Central

PubMed publication ID

1826787

retrieved

27 April 2018

reference URL

http://europepmc.org/abstract/MED/1826787

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52238849&oldid=2215242748"